Both the DSMC, Dr. Dhody, Nader and everyone else

Both the DSMC, Dr. Dhody, Nader and everyone else seems to be operating on the supposition that an EUA is the same as a BLA. FDA guidance for BLA is "an effective treatment" with a good safety profile. Guidance for an EUA is "may be effective" with a good safety profile. p = .05 is better than "may be effective" and whatever our lower p value is certainly surpasses that.

Time is of the essence not only for patients but for approval of leronlimab. DOD says the emergency is over or a subpar drug gets approval in severe/critical we might as well shut down the trial and wait for HIV approval. And this I will lay directly at NP's door.